Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Biomarkers Summit

16 Jan 2013 - 17 Jan 2013 - London, UK



Bookmark and Share


Innovations in stratified medicine.

Book by 28th September 2012 to receive a £300 discount

Visit www.biomarkers-summit.asp to claim your discount now!

Drawing on advances in genomics, proteomics and next-generation sequencing, SMi’s 6th annual Biomarkers Summit brings you the latest developments in this exciting field. From compound screening and toxicity testing to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development. You cannot afford to miss this event

Reasons to attend this exciting event include:

Accelerate companion diagnostics development for therapeutic indications

Validate and deliver biomarkers for patient selection during clinical trials

Implement sub-grouping in patient segmentation studies

Utilise revised FDA regulatory guidelines to aid product development

Optimise reimbursement strategies for diagnostics

Maximise biomarker identification using epigenetic and metabolomic insights

Key speakers include:

Adam Platt, Diagnostic Development Director, AstraZeneca
Andrew Warren, Director, PK/PD/Immunogenicity Bioanalysis, Novartis Pharma
Christopher Foley, Clinical Imaging Manager, GlaxoSmithKline
Graham Bell, Lead Technologist, Stratified Medicine, Technology Strategy Board
Mirella Lazarov, Senior Director Biology, Head of Biomarkers, Gilead Sciences
Nicholas Buss, Toxicology Project Leader, MedImmune
Nick Crabb, Associate Director - Diagnostics Assessment Programme, National Institute for Health and Clinical Excellence

Contact Farhaan Rahman on tel +44 0207 827 6186 or emailfrahman@smi-online.co.uk



Further information
Scientific News
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
‘NoBody,’ a Microprotein On a Mission
Researchers identify over 400 microproteins encoded in the human genome, one of which clears unneeded genetic material inside cells.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Largest Resource of Protein-Protein Interactions
Researchers have developed the largest ever database of protein-protein interactions.
Bright Red Fluorescent Protein Created
Scientists have created a bright red, fluorescent protein that could be used to track essential cellular processes.
Protein Self-Regulates Abundance
Researchers have uncovered how a protein, that plays a crucial role in embryonic stem cell renewal, is regulated.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Building Better Nanodiscs
Researchers have improved upon the design of nanodiscs that provide an unprecedented view of viral infection.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!